In the same study, the authors demonstrated that CD19+ cells could be detected in all tumor samples and on average made up 8.9% of the CD45+ lymphocytic infiltrate of colorectal cancers compared to 5.1% of the CD45+ peripheral blood. This evidence concerns the gene CD19 and colorectal cancer.